Gyeonggi-do, South Korea

Hyun-Jung Kwak




Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2022)
  • Suwon-si, KR (2023)

Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Profile: Hyun-Jung Kwak

Introduction

Hyun-Jung Kwak is an esteemed inventor based in Gyeonggi-do, South Korea, recognized for his contributions to the field of pharmaceuticals. With two patents to his name, he is a leading figure in the development of innovative compounds aimed at addressing metabolic disorders.

Latest Patents

Kwak's most recent patents include significant advancements in the area of phenyl propionic acid derivatives. These innovations, described as compounds of Formula (I), encompass racemates, enantiomers, diastereomers, and pharmaceutical salts. His discoveries demonstrate GPR40 agonist activity, which has the potential to modulate blood glucose levels effectively. The patented compounds are particularly notable for their capability to enhance glucose-dependent insulin secretion mechanisms, providing an effective approach to managing type 2 diabetes without the risk of hypoglycemia. This means the compounds and their corresponding pharmaceutical compositions serve as promising options for preventing and treating type 2 diabetes through precise control of blood glucose levels.

Career Highlights

Hyun-Jung Kwak's affiliation with Il Dong Pharmaceutical Co., Ltd. has facilitated his groundbreaking research and development efforts. His work concentrates on creating therapeutic solutions that offer significant benefits to those suffering from diabetes and related metabolic conditions. The effectiveness and safety of his patented compounds mark a notable milestone in pharmaceutical innovation.

Collaborations

Throughout his career, Kwak has collaborated with talented professionals in the field, including his colleagues Jae-Hoon Kang and Hong-Sub Lee. These partnerships have enabled the exchange of ideas and expertise, fostering an environment of innovation and efficiency in the creation of new therapeutic agents.

Conclusion

Hyun-Jung Kwak stands out as a remarkable inventor in the pharmaceutical industry, making substantial strides in the treatment of metabolic disorders. His patents not only contribute to scientific knowledge but also hold the potential to enhance the quality of life for countless individuals affected by type 2 diabetes. As he continues to innovate, the impact of his work is likely to be felt for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…